Outcomes of Periacetabular Osteotomy for Borderline Acetabular Dysplasia

医学 骨成形术 髋关节镜检查 外科 关节镜检查 前瞻性队列研究 股骨髋臼撞击 发育不良 最小临床重要差异 随机对照试验 内科学
作者
Jeffrey J. Nepple,Frank W. Parilla,Gail Pashos,John C. Clohisy
出处
期刊:Journal of Bone and Joint Surgery, American Volume [Wolters Kluwer]
卷期号:105 (2): 137-144 被引量:42
标识
DOI:10.2106/jbjs.22.00491
摘要

Background: The optimal surgical treatment (hip arthroscopy compared with periacetabular osteotomy [PAO]) for borderline acetabular dysplasia (lateral center-edge angle [LCEA], 18° to 25°) remains a topic of debate. To date, the literature has focused primarily on arthroscopy outcomes, with only a few small reports on PAO outcomes. The purpose of this study was to define PAO outcomes in a large cohort of borderline hips. In a secondary analysis, we assessed the effect of prior failed arthroscopy, concurrent hip arthroscopy, and concurrent femoral osteoplasty on PAO outcomes in this cohort. Methods: A prospective database was retrospectively reviewed for patients who underwent PAO for symptomatic instability in the setting of borderline dysplasia (LCEA, 18° to 25°). Of the 232 identified hips, 186 (80.2%) were assessed at a mean follow-up of 3.3 ± 2.0 years postoperatively. The mean patient age was 25.2 ± 8.5 years (range, 14 to 45 years), and 88.2% were female. Thirty hips (16.1%) had undergone a failed prior arthroscopy. Arthroscopy was performed concurrently with the PAO in 130 hips (69.9%), and femoral osteoplasty was performed concurrently in 120 hips (64.5%). The modified Harris hip score (mHHS) was assessed relative to the minimal clinically important difference (MCID) of 8 and patient acceptable symptom state (PASS) of 74. Clinical failure was defined as a reoperation for persistent symptoms or a failure to achieve either the mHHS MCID or PASS. Results: Of the 156 hips undergoing a primary surgical procedure, clinical success was achieved in 148 hips (94.9% [95% confidence interval (CI), 90.2% to 97.4%]). Two hips (1.3% [95% CI, 0.4% to 4.6%]) underwent reoperation (hip arthroscopy) for persistent symptoms and an additional 6 hips (3.8% [95% CI, 1.8% to 8.1%]) failed to achieve the mHHS MCID or PASS, for a clinical failure rate of 5.1% (95% CI, 2.6% to 9.8%); 8.8% reported dissatisfaction with the surgical procedure. Clinical failure was more frequent among the 30 hips (23.3% [95% CI, 11.8% to 40.9%]; p = 0.001) that had undergone a prior failed arthroscopy. There were no outcome differences between hips that had or had not undergone concurrent hip arthroscopy or femoral osteoplasty. Conclusions: This study demonstrates excellent early outcomes of PAO for borderline acetabular dysplasia, with significant clinical improvement in 94.9% of patients undergoing a primary surgical procedure; 91.2% were satisfied with the surgical procedure. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Jasper应助劼大大采纳,获得10
刚刚
1秒前
1秒前
2秒前
2秒前
2秒前
可爱的函函应助lu采纳,获得10
2秒前
校长完成签到,获得积分20
3秒前
刘振扬完成签到 ,获得积分10
3秒前
4秒前
4秒前
黄新绒发布了新的文献求助10
4秒前
顾矜应助Tree采纳,获得10
4秒前
4秒前
螺丝老人发布了新的文献求助10
5秒前
Eton完成签到,获得积分10
5秒前
ljy应助linkman采纳,获得10
5秒前
老实人品牌完成签到,获得积分10
5秒前
莫得感情发布了新的文献求助10
6秒前
6秒前
6秒前
大力芙发布了新的文献求助10
7秒前
蝶步韶华发布了新的文献求助10
7秒前
7秒前
王光勋完成签到,获得积分10
8秒前
木糖醇发布了新的文献求助10
9秒前
9秒前
英吉利25发布了新的文献求助10
9秒前
9秒前
打打应助酷酷珠采纳,获得10
9秒前
优雅的枫叶完成签到,获得积分10
10秒前
10秒前
发仔完成签到,获得积分10
10秒前
难过的谷芹应助黄新绒采纳,获得10
10秒前
DDDD发布了新的文献求助30
10秒前
tjr发布了新的文献求助10
11秒前
hello_25baby完成签到,获得积分10
12秒前
曾经的采波完成签到 ,获得积分10
12秒前
12秒前
Hello应助洁净笑白采纳,获得10
12秒前
高分求助中
(禁止应助)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Functional High Entropy Alloys and Compounds 1000
Building Quantum Computers 1000
Apiaceae Himalayenses. 2 500
Molecular Cloning: A Laboratory Manual (Fourth Edition) 500
Social Epistemology: The Niches for Knowledge and Ignorance 500
优秀运动员运动寿命的人文社会学因素研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4239267
求助须知:如何正确求助?哪些是违规求助? 3773047
关于积分的说明 11849138
捐赠科研通 3428810
什么是DOI,文献DOI怎么找? 1881789
邀请新用户注册赠送积分活动 933952
科研通“疑难数据库(出版商)”最低求助积分说明 840616